Key result
Five cardiometabolic risk factors linked to ~6-fold greater risk of moderate/severe eGFR decline versus none.
Why the study?
Although individual cardiometabolic risk factors contribute to reduced kidney function, their cumulative impact and population-specific differences remain unclear.
Does cumulative cardiometabolic risk factor burden increase the risk of estimated glomerular filtration rate decline in middle-aged and older adults?
Cross-Sectional (n=19,416)
Yes
Does cumulative cardiometabolic risk factor burden increase the risk of estimated glomerular filtration rate decline in middle-aged and older adults?
Effect estimate: RRR 6.178 (95% CI 3.718-10.268)
There is a graded association between the cumulative burden of cardiometabolic risk factors and eGFR decline in middle-aged and older adults, highlighting the importance of cardiometabolic screening for kidney health.
"Highlights the dose-dependent association between cumulative cardiometabolic risk factors and e.
Individual cardiometabolic risk factors (CMRFs) are contributors to reduced kidney function, their cumulative impact and population-specific differences remain unclear. This cross-sectional study investigated the association between incremental CMRFs and estimated glomerular filtration rate (eGFR). We analyzed data from two nationally representative surveys, China Health and Retirement Longitudinal Study wave 3 (N = 10,043) and the U.S. Health and Retirement Study wave 13 (N = 9,373), comprising 19,416 participants aged ≥45 years. Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations, integrating serum creatinine and cystatin C, were applied to calculate eGFRscr-cysc, categorized into normal (≥90 mL/min/1.73 m²), mildly decreased (60-89 mL/min/1.73 m²), and moderately/severely decreased (<60 mL/min/1.73 m²). Multinomial logistic regression was employed to assess the association between cumulative CMRFs (0-5) and eGFRscr-cysc categories, adjusting for covariables. Analyses were conducted on unweighted data without applying complex survey sampling weights. A graded association between the cumulative burden of CMRFs and eGFRscr-cysc decline was observed. Each additional CMRF was associated with an increased risk of mild eGFRscr-cysc decline in the fully adjusted model (relative risk ratio [RRR] = 1.141, 95% confidence interval [95% CI]: 1.108-1.175) and moderate/severe eGFRscr-cysc decline (RRR = 1.433, 95% CI: 1.364-1.505). Participants with five CMRFs had a significantly higher risk of moderate/severe eGFRscr-cysc decline compared to those without CMRFs (RRR = 6.178; 95% CI: 3.718-10.268). Predictive margins showed that eGFRscr-cysc decline was more prevalent in the American population compared to the Chinese population. These cross-sectional findings suggest that integrating routine screening and management of cardiometabolic risk factors into CKD prevention programs may help protect kidney health in aging populations.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2026) conducted a cross-sectional in Reduced kidney function (n=19,416). Cumulative cardiometabolic risk factors (CMRFs) vs. No CMRFs was evaluated on Moderate/severe eGFR decline (<60 mL/min/1.73 m2) (RRR 6.178, 95% CI 3.718-10.268). The presence of five cardiometabolic risk factors was associated with a significantly higher risk of moderate/severe eGFR decline compared to zero risk factors (RRR 6.178; 95% CI 3.718-10.268).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: